MHLW Sets Donations Limit Of ¥5 Million To Drug Review Board Members
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare has set a maximum ¥5 million per year as the donations limit to its outside drug review board members. The ruling also pertains to competitors of a pharmaceutical company that is applying for a new drug approval. Since last April, when a research team inside MHLW was found to have received large donations from Tamiflu's Japanese importer, the Ministry has strengthened rules on receiving donations from drug companies. (Click here for more - Japanese language